Ads
related to: hepatitis blonglastingliver.com has been visited by 10K+ users in the past month
Search results
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoOn that front, there is little to worry about. Gilead Sciences isn't just an HIV company, though....
‘Unusual’ cancers emerged after the pandemic. Doctors ask if COVID is to blame.
Anchorage Daily News· 6 days agoKashyap Patel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
The Hunt for Virus Treatments Continues Post Covid-19
Digital Journal· 6 days agoVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 7, 2024) - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and ...
Oregon to receive $15 million in settlement over baby powder lawsuit
The Bulletin· 2 days agoOregon will receive $15 million from Johnson & Johnson to settle allegations that the pharmaceutical...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 4 days agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares of the medical ...
Let’s Talk: Sexually Transmitted Infections
Tahoe Daily Tribune· 5 days agoSexually transmitted infections (STIs) are on the rise in the United States. STIs are infections passed from person to person through sexual contact....
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the firm, Marketbeat reports. One ...
BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of...
Lodi News-Sentinel· 6 days agoBioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that new data supporting the long-term safety and efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) will be presented at the ...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
The News & Observer· 3 days agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
Vir Biotechnology (NASDAQ:VIR) Trading Down 8%
ETF DAILY NEWS· 5 days agoVir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s stock price was down 8% during mid-day trading on Friday . The stock traded as low as $11.02 and last traded at $11.02. Approximately ...
